Sibel Health, a Chicago, IL-based medical technology company, raised $30M in Series C funding.
The round was led by the Steele Foundation for Hope with participation from Dräger. The Steele Foundation for Hope previously led Sibel’s Series B round, adding an additional $20M investment. Dräger previously led Sibel’s Series A round, contributing $10M more in funding.
The company intends to use the funds to expand operations and its R&D efforts.
Led by CEO Steve Xu and CTO Jong Yoon Lee, Sibel Health is a medical technology company providing advanced monitoring solutions for patients of all ages in the home or hospital. Enabled by advanced clinical-grade wearable sensors, the ANNE® One platform offers wireless monitoring of all vital signs for patients 12 years and older. This financing is timed to Sibel’s newest FDA 510(k) clearance enabling alarms and alerts along with a central station.
The company also has an international office in Seoul, South Korea. In early 2024, the firm was awarded a $17.5M dollar award grant from the Gates Foundation.
